Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer
Patients experiencing pCR had better outcomes. cT, cN, and subtype were prognostic only in patients with RD.
Authors
- Melissa E. Hughes (ORCID: https://orcid.org/0000-0001-6190-9101)
- Tonia Parker
- Alyssa R. Martin
- Tyzaire S. Duporte
- Nancy U. Lin
- Sara M. Tolaney
- Chiara Corti
- Giuseppe Curigliano
- Tari A. King
- Elizabeth A. Mittendorf
- Tianyu Li
- Nabihah Tayob
Institutions
- Brigham and Women's Hospital (US)
- Dana-Farber Cancer Institute (US)
- Dana-Farber Brigham Cancer Center (US)
- European Institute of Oncology (IT)
Publication Details
- Journal
- The Breast
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.breast.2026.104765
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00